These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6130769)

  • 41. Relationships between glutamine, glutamate, and GABA in nerve endings under Pb-toxicity conditions.
    Struzyńska L; Sulkowski G
    J Inorg Biochem; 2004 Jun; 98(6):951-8. PubMed ID: 15149801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Axonal transport of [3H] GABA and [3H] glutamate in excitatory and inhibitory neurons innervating lobster exoskeletal musculature.
    Woodward WR
    J Neurobiol; 1984 Jan; 15(1):49-65. PubMed ID: 6199461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transport and metabolism of glutamate and GABA in neurons are glial cells.
    Schousboe A
    Int Rev Neurobiol; 1981; 22():1-45. PubMed ID: 6115823
    [No Abstract]   [Full Text] [Related]  

  • 44. Modulation of glutamate release from hippocampal mossy fiber nerve endings by arachidonic acid and eicosanoids.
    Dorman RV; Hamm TF; Damron DS; Freeman EJ
    Adv Exp Med Biol; 1992; 318():121-36. PubMed ID: 1353285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The effect of membrane protein methylation processes on the binding of [14C]-GABA by nerve endings in the brain of white rats].
    Vartanian AA; Aprikian GV; Vaniushin BF
    Dokl Akad Nauk SSSR; 1989; 305(4):1003-6. PubMed ID: 2546722
    [No Abstract]   [Full Text] [Related]  

  • 46. GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors.
    Waldmeier PC; Wicki P; Feldtrauer JJ; Mickel SJ; Bittiger H; Baumann PA
    Br J Pharmacol; 1994 Dec; 113(4):1515-21. PubMed ID: 7889310
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cholinergic nerve terminals of human cerebral cortex possess a GABA transporter whose activation induces release of acetylcholine.
    Bonanno G; Ruelle A; Andrioli GC; Raiteri M
    Brain Res; 1991 Jan; 539(2):191-5. PubMed ID: 2054596
    [TBL] [Abstract][Full Text] [Related]  

  • 48. σ-1 Receptor agonist SKF10047 inhibits glutamate release in rat cerebral cortex nerve endings.
    Lu CW; Lin TY; Wang CC; Wang SJ
    J Pharmacol Exp Ther; 2012 May; 341(2):532-42. PubMed ID: 22357973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution of input synapses from processes exhibiting GABA- or glutamate-like immunoreactivity onto terminals of prosternal filiform afferents in the locust.
    Watson AH; Pflüger HJ
    J Comp Neurol; 1994 May; 343(4):617-29. PubMed ID: 7913475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurochemical effects of nicotine on glutamate and GABA mechanisms in the rat brain.
    Pérez de la Mora M; Méndez-Franco J; Salceda R; Aguirre JA; Fuxe K
    Acta Physiol Scand; 1991 Feb; 141(2):241-50. PubMed ID: 1675543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Glutamic acid as a possible central neurotransmitter].
    Takagaki G
    No Shinkei Geka; 1977 Dec; 5(13):1311-7. PubMed ID: 23502
    [No Abstract]   [Full Text] [Related]  

  • 52. Glutamic acid and excitatory nerve endings: reduction of glutamic acid uptake after axotomy.
    Storm-Mathisen J
    Brain Res; 1977 Jan; 120(2):379-86. PubMed ID: 832132
    [No Abstract]   [Full Text] [Related]  

  • 53. [The effect of ethanol on gamma-aminobutyric acid in the brain].
    Lassánová M; Turský T; Homerová D
    Bratisl Lek Listy; 1989 Dec; 90(12):875-84. PubMed ID: 2576392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Content of components GABA metabolism in the brain of cats and rats].
    Snisar' IA; Orekhov VS
    Ukr Biokhim Zh (1978); 1982; 54(5):565-8. PubMed ID: 6127826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of gamma-aminobutyric acid on nerve terminal excitability in a slice preparation of cuneate nucleus.
    Hayes AG; Simmonds MA
    Br J Pharmacol; 1978 Jul; 63(3):503-7. PubMed ID: 667494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultrastructural distribution of glutamate immunoreactivity within neurosecretory endings and pituicytes of the rat neurohypophysis.
    Meeker RB; Swanson DJ; Greenwood RS; Hayward JN
    Brain Res; 1991 Nov; 564(2):181-93. PubMed ID: 1687373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition by Diazepam and γ-Aminobutyric Acid of Depolarization-Induced Release of [¹⁴C]Cysteine Sulfinate and [³H]Glutamate in Rat Hippocampal Slices.
    Baba A; Okumura S; Mizuo H; Iwata H
    J Neurochem; 1983 Jan; 40(1):280-4. PubMed ID: 6129289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glutamate, GABA, and CNS disease: a review.
    Walker JE
    Neurochem Res; 1983 Apr; 8(4):521-50. PubMed ID: 6136926
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of pH in the isolation of nerve ending particles which transport GABA and glutamic acid.
    Kitzemann RJ
    J Neurochem; 1979 Feb; 32(2):669-72. PubMed ID: 33236
    [No Abstract]   [Full Text] [Related]  

  • 60. A bioluminescent gamma-aminobutyrate assay for monitoring its release from inhibitory nerve endings.
    Israël M; Lesbats B
    J Neurochem; 1996 Dec; 67(6):2624-7. PubMed ID: 8965088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.